Tag: POI
-
HPO Axis and Brain Aging: Ovarian Disorders Explained
Introduction: Connecting the HPO Axis to Brain Aging The hypothalamic‑pituitary‑ovarian (HPO) axis sits at the center of female reproductive health, orchestrating ovulation through a delicate balance of hormones. Recent reviews highlight how disruptions in this axis not only drive ovarian disorders such as menopause, primary ovarian insufficiency (POI), and polycystic ovary syndrome (PCOS) but may…
-
The HPO Axis, Ovarian Disorders, and Brain Aging: Connecting Reproductive Health to Neurodegeneration
Understanding the HPO Axis and Its Role in Reproductive Health The hypothalamic-pituitary-ovarian (HPO) axis is a finely tuned endocrine system that governs female reproduction. It starts in the hypothalamus, where gonadotropin-releasing hormone (GnRH) prompts the pituitary to secrete luteinizing hormone (LH) and follicle-stimulating hormone (FSH). These hormones, in turn, regulate ovarian follicle development and the…
-
Ireland Advances Phase 2 of National Precision Oncology Program to Personalize Cancer Care
Ireland launches Phase 2 of its national precision oncology program On 8 October, Ireland marked a significant milestone in its fight against cancer as Minister for Further and Higher Education, Research, Innovation and Science James Lawless TD unveiled Phase 2 of Precision Oncology Ireland (POI). This country-wide effort stands as the largest and most ambitious…
-
Ireland Expands Precision Oncology Ireland: Phase 2 Launch Poised to Transform Cancer Care
Ireland Launches Phase 2 of its National Precision Oncology Program On 8 October, Ireland marked a significant milestone in its fight against cancer with the launch of Phase 2 of Precision Oncology Ireland (POI). The event signals a bold expansion of the country’s leading cancer research program, built to advance personalised cancer research and patient…
-
Ireland launches phase 2 of €28m Precision Oncology Ireland programme to accelerate personalised cancer care
Phase 2 kicks off for Ireland’s largest cancer research initiative Ireland’s leading cancer research programme, Precision Oncology Ireland (POI), has received a €28 million co-funding boost to move into its second phase. The expansion aims to scale the collaborative model established in POI’s inaugural phase and to deepen ties between researchers, clinicians, industry partners, charities,…